Pasteurella Pneumonia

Pasteurella pneumonia is a significant bacterial respiratory disease affecting multiple species of farm animals including cattle, sheep, goats, pigs, and poultry worldwide. The condition is caused by bacteria from the Pasteurellaceae family, primarily Pasteurella multocida and Mannheimia haemolytica, organisms that commonly inhabit the upper respiratory tract of healthy animals as commensal organisms. Under normal circumstances, these bacteria coexist harmlessly with their hosts, but when animals experience stress, viral infections, or other immunosuppressive conditions, these opportunistic pathogens can invade the lower respiratory tract and establish severe, life-threatening pneumonia. The disease represents one of the most economically significant respiratory conditions in livestock production due to its frequency, treatment costs, and impact on animal performance.

Pasteurella pneumonia occurs globally wherever livestock are raised, with prevalence varying based on management practices, environmental conditions, and production systems. The condition is particularly common in intensive production systems where animals are housed in close proximity, facilitating bacterial transmission. Young animals are disproportionately affected, with calves, lambs, and piglets showing the highest incidence rates. Seasonal patterns are evident in many regions, with increased cases during periods of temperature fluctuation, high humidity, or when animals are moved or mixed. Both acute outbreaks affecting multiple animals and sporadic individual cases occur depending on the predisposing factors present.

The economic impact of Pasteurella pneumonia extends beyond direct mortality to include treatment costs, reduced growth rates, poor feed conversion, and long-term lung damage that compromises lifetime productivity. Mortality rates in untreated cases can exceed 30 percent, while even successfully treated animals often suffer permanent lung scarring that reduces their respiratory capacity and athletic ability. The costs of antimicrobial treatment, veterinary services, and additional labor for animal care accumulate quickly during outbreaks. Perhaps most significantly, subclinical cases that escape diagnosis can result in chronic poor performers that never reach their genetic potential, representing hidden economic losses that are difficult to quantify but nonetheless substantial.

Early recognition and prompt treatment significantly improve outcomes for animals with Pasteurella pneumonia, making awareness of this condition essential for livestock producers. The disease responds well to appropriate antimicrobial therapy when treatment is initiated before extensive lung damage occurs, but delays in treatment dramatically worsen prognosis. Understanding the predisposing factors that convert normal respiratory flora into pathogenic invaders allows producers to implement management practices that reduce disease incidence. Working with a licensed veterinarian to establish treatment protocols, vaccination programs, and management modifications provides the foundation for effective Pasteurella pneumonia control in livestock operations of all types and sizes.

Pasteurella pneumonia is caused primarily by bacteria from two closely related genera within the family Pasteurellaceae, specifically Pasteurella multocida and Mannheimia haemolytica. Pasteurella multocida is a gram-negative coccobacillus that occurs in multiple capsular types designated A through F, with different types showing preferences for different host species. Mannheimia haemolytica, previously classified as Pasteurella haemolytica, is the primary cause of severe pneumonic pasteurellosis in cattle and sheep, with serotype A1 being most commonly associated with disease in cattle and serotype A2 predominating in sheep. Both organisms are normal inhabitants of the nasopharynx in healthy animals, establishing a carrier state that persists throughout life. Understanding that these bacteria are typically present even in healthy animals emphasizes that disease development requires additional factors beyond mere bacterial presence.

While no direct genetic predisposition to Pasteurella infection has been established, certain breed characteristics and individual variations in immune competence influence susceptibility to clinical disease. Bos indicus cattle breeds and their crosses may demonstrate somewhat greater resistance to respiratory disease compared to Bos taurus breeds, possibly related to differences in immune function or stress response. Individual animals within any breed show variation in their ability to resist bacterial colonization of the lower respiratory tract and to mount effective immune responses against established infections. This individual variation explains why some animals develop severe disease while flockmates or herdmates with similar exposure remain healthy. Selection for robust animals with good health histories may gradually improve population resistance over generations.

Environmental and management factors play critical roles in converting commensal bacteria to pathogenic invaders, with stress being the most important predisposing element. Transportation stress is particularly significant, creating the condition known as shipping fever when cattle develop pneumonia following movement. Temperature extremes, rapid weather changes, poor ventilation, high humidity, and dusty conditions all increase respiratory disease risk. Overcrowding concentrates pathogens and increases transmission pressure while simultaneously creating social stress. Nutritional deficiencies, particularly of trace minerals and vitamins essential for immune function, compromise host defenses. Poor colostrum management in young animals leaves them with inadequate passive immunity during the vulnerable early weeks of life.

Risk factors for Pasteurella pneumonia are well characterized and help identify animals requiring heightened surveillance or preventive intervention. Young animals face the highest risk, with calves between weaning and one year of age being particularly vulnerable. Recently weaned animals experience combined stresses of separation from dams, dietary change, and often movement and mixing with unfamiliar animals. Newly purchased animals entering a farm bring new pathogen strains and face adaptation stress. Animals with recent viral respiratory infections have compromised respiratory defenses that facilitate bacterial invasion. Commingling animals from multiple sources creates exposure to novel bacterial strains while simultaneously inducing social stress from hierarchy establishment.

The pathophysiology of Pasteurella pneumonia involves a complex cascade beginning with compromise of normal respiratory defenses and culminating in severe lung inflammation and tissue destruction. Primary viral infections damage the respiratory epithelium and impair the mucociliary clearance mechanism that normally sweeps pathogens up and out of the airways. Stress hormones suppress immune cell function, particularly the activity of alveolar macrophages that provide first-line defense against bacteria reaching the lower airways. With defenses compromised, Pasteurella organisms descend from the upper respiratory tract into the lungs, where they multiply rapidly in the warm, moist, nutrient-rich environment. Bacterial toxins, particularly the leukotoxin produced by Mannheimia haemolytica, destroy immune cells and trigger intense inflammatory responses. The resulting pneumonia features massive neutrophil infiltration, fibrin deposition, and tissue necrosis that can progress to consolidated lung lobes and pleuritis within hours to days.

Early warning signs of Pasteurella pneumonia are often subtle and easily overlooked in busy livestock operations, making vigilant observation essential for timely intervention. Affected animals may initially show decreased feed intake, being slow to come to the feed bunk or showing less enthusiasm at feeding time than normal. A mild increase in respiratory rate may be present before other signs develop, though this requires baseline knowledge of normal respiratory patterns to detect. Slight depression with less engagement in normal social behaviors and activities provides another early indicator. Animals may stand with their heads slightly lowered or show mild reluctance to move with the group. Early nasal discharge is typically serous or clear before progressing to the mucopurulent discharge characteristic of established disease.

Common symptoms vary somewhat between species, though the fundamental respiratory disease process produces similar clinical pictures across cattle, sheep, goats, and other affected livestock. In cattle, classic signs include fever often exceeding 104°F (40°C), depression, anorexia, and rapid shallow breathing with an increased abdominal component. Nasal discharge progresses from clear to thick yellow or green purulent material that may crust around the nostrils. Sheep and goats show similar signs but may deteriorate more rapidly given their smaller body size. Pigs often present with paroxysmal coughing fits and may show dog-sitting posture as they struggle to breathe. Poultry affected by Pasteurella show swelling of facial structures, ocular and nasal discharge, and respiratory distress that distinguishes the condition from other respiratory diseases.

Behavioral changes in animals with Pasteurella pneumonia reflect both the systemic illness and the respiratory distress characteristic of the condition. Affected animals separate themselves from the group, often standing alone at the periphery or seeking out quiet areas away from herd activity. Feed and water intake decline significantly, with animals making occasional attempts to eat but giving up quickly. Reluctance to move becomes pronounced, with affected animals lagging behind when the group moves or resisting being driven. The normal alertness and responsiveness to environmental stimuli decreases as the animal becomes increasingly focused on the effort of breathing. Rumination decreases or ceases in cattle, sheep, and goats as systemic illness suppresses normal digestive activity.

Physical signs observed on examination provide important diagnostic information and help assess disease severity. Elevated rectal temperature, often 104-107°F (40-41.7°C) in acute cases, indicates active infection and inflammatory response. Respiratory rate increases significantly, often to double or triple normal values, with shallow breaths that minimize painful chest expansion. Auscultation of the lungs reveals harsh breath sounds, crackles, and areas of consolidation where normal lung sounds are absent. Nasal discharge ranging from mucopurulent to frankly purulent material may be bilateral or more pronounced on one side corresponding to the most severely affected lung. Coughing, which may be spontaneous or induced by tracheal palpation, is typically moist and productive. Extended head and neck posture and open-mouth breathing indicate severe respiratory compromise.

Symptom progression in untreated Pasteurella pneumonia follows a predictable and alarming trajectory of deterioration. Initial signs of mild depression and decreased appetite progress within 24-48 hours to obvious illness with high fever and respiratory distress. The disease can progress from first noticeable signs to life-threatening illness within 1-3 days, emphasizing the need for rapid response. As pneumonia extends and consolidation involves larger portions of the lung, respiratory function deteriorates progressively. Pleuritis develops in many cases, adding severe chest pain that further restricts breathing. Without treatment, affected animals may die within 3-7 days of initial illness onset, though some develop chronic pneumonia with persistent lung damage if they survive the acute phase.

Emergency symptoms requiring immediate veterinary intervention include severe respiratory distress, open-mouth breathing, cyanosis (blue coloration of mucous membranes), complete anorexia, recumbency, and temperatures exceeding 106°F (41.1°C). Animals showing extreme neck extension with elbows abducted to maximize chest expansion face immediate risk of respiratory failure. Bloody or blood-tinged nasal discharge suggests severe lung damage with necrosis and hemorrhage. Any animal that has progressed to recumbency due to respiratory disease requires urgent assessment, as these cases often have poor prognosis regardless of treatment. Sudden death without premonitory signs can occur with peracute Mannheimia haemolytica infection, particularly in cattle, making any respiratory disease outbreak an emergency situation warranting immediate veterinary consultation.

Clinical examination forms the foundation of Pasteurella pneumonia diagnosis, with experienced veterinarians often able to make presumptive diagnoses based on history and physical findings. The examination begins with observation of the animal's overall demeanor, respiratory effort, and any obvious nasal discharge before handling. Temperature measurement reveals the fever characteristic of active bacterial infection. Careful auscultation of all lung fields identifies areas of abnormal breath sounds, consolidation, or pleural friction rubs indicating pleuritis. Palpation of peripheral lymph nodes may reveal enlargement of prescapular or other nodes draining affected areas. The clinical picture of fever, respiratory distress, nasal discharge, and abnormal lung sounds in an animal with recent stress exposure provides strong presumptive evidence of bacterial pneumonia.

Diagnostic testing helps confirm the bacterial cause and may guide antimicrobial selection for treatment. Deep nasopharyngeal swabs or transtracheal wash samples can be collected for bacterial culture and sensitivity testing, identifying the specific organisms involved and their susceptibility patterns. Serological tests play limited role in acute diagnosis but may help with epidemiological investigations. Complete blood count typically shows elevated white blood cell counts with a left shift indicating active bacterial infection. Blood chemistry may reveal changes associated with dehydration and systemic inflammation. Thoracic ultrasound, increasingly available on farms, can identify lung consolidation, pleural effusion, and abscess formation. Radiography provides detailed imaging where available but is impractical for large animals in field settings.

Differential diagnosis for livestock presenting with respiratory disease includes multiple viral and bacterial conditions that produce overlapping clinical signs. Infectious bovine rhinotracheitis and bovine viral diarrhea in cattle cause respiratory disease that may predispose to or occur concurrently with bacterial pneumonia. Mycoplasma species cause respiratory disease in cattle, sheep, and goats that can be difficult to distinguish from Pasteurella infection clinically. Lungworm infection produces respiratory signs, particularly in cattle and sheep, though typically with less fever and acute illness. Aspiration pneumonia following drenching accidents or recumbency presents similarly but has a distinct history. Parasitic pneumonia, fungal infections, and other bacterial pathogens must be considered based on species and regional disease prevalence.

Herd-level diagnostics become important when Pasteurella pneumonia affects multiple animals, suggesting common risk factors requiring correction. Postmortem examination of animals that die or are euthanized provides definitive diagnosis through characteristic gross and microscopic lung lesions combined with bacterial isolation from affected tissues. Environmental assessment identifies risk factors such as poor ventilation, overcrowding, or dusty conditions contributing to disease. Review of recent management events including transportation, commingling, processing procedures, and feed changes helps identify precipitating stressors. Evaluation of vaccination history and timing relative to disease onset assesses whether vaccination failure or inadequate coverage contributed to the outbreak. This herd-level investigation guides both immediate outbreak management and longer-term prevention strategies.

Emergency treatment for Pasteurella pneumonia focuses on rapid initiation of antimicrobial therapy and supportive care to prevent disease progression and death. Time is critical, as treatment delays measured in hours can mean the difference between recovery and death or between complete recovery and permanent lung damage. Broad-spectrum antimicrobial therapy should begin immediately based on clinical diagnosis without waiting for culture results, as the organisms responsible are predictable and delay is dangerous. Injectable formulations achieve rapid therapeutic blood levels more reliably than oral products in sick animals with potentially compromised gastrointestinal function. Non-steroidal anti-inflammatory drugs provide fever reduction, pain control, and may limit some of the inflammatory damage occurring in the lungs.

Medical management relies primarily on antimicrobial therapy targeting Pasteurella and Mannheimia species, with drug selection based on regional susceptibility patterns, cost, and withdrawal time considerations. Oxytetracycline, tilmicosin, tulathromycin, florfenicol, and ceftiofur represent commonly used first-line options with good efficacy against respiratory pathogens. Long-acting formulations reduce handling stress and ensure sustained drug levels during the critical treatment period. Treatment duration varies by drug but typically requires maintenance of therapeutic levels for at least 5-7 days. Antimicrobial resistance is an increasing concern, making veterinary guidance essential for appropriate drug selection. All treatments in food-producing animals must be used according to label directions or under veterinary prescription with careful attention to meat and milk withdrawal times to ensure food safety.

Surgical intervention plays minimal role in Pasteurella pneumonia management, as the diffuse lung involvement precludes surgical approaches. However, in rare cases where pulmonary abscesses develop following acute disease, surgical drainage might be considered in valuable individual animals. Pleuritis with significant pleural effusion may occasionally require thoracocentesis to drain accumulated fluid and relieve respiratory compromise, though this is uncommon. The primary role of the veterinarian remains medical management rather than surgical intervention. In most cases, the response to appropriate antimicrobial therapy makes surgical considerations unnecessary.

Supportive care complements antimicrobial therapy and may determine outcome in severely affected animals. Ensuring adequate hydration through provision of clean, fresh water or intravenous fluid therapy in severe cases supports cardiovascular function and drug distribution. Minimizing stress through quiet handling, avoiding unnecessary movement, and providing comfortable housing reduces oxygen demand. Maintaining feed intake with palatable, easily consumed feeds supports immune function and healing. Temperature management through shelter from extreme heat or cold reduces metabolic stress. Separating affected animals from healthy herdmates reduces disease spread while allowing closer monitoring and care.

Herd treatment protocols address outbreak situations where multiple animals are affected or at risk. Metaphylactic treatment of all at-risk animals with antimicrobials during high-risk periods such as arrival at feedlots can reduce disease incidence and severity. Mass medication through feed or water is occasionally used but provides less reliable drug delivery than individual injection. Identification and prioritized treatment of visibly affected animals combined with monitoring of exposed animals guides resource allocation during outbreaks. Environmental modifications addressing ventilation, stocking density, and dust control complement medical intervention. Vaccination of unaffected animals may help limit outbreak extension, though existing infection will not be prevented by vaccination.

Treatment decision factors in Pasteurella pneumonia balance animal welfare, economic considerations, and food safety requirements. Early-stage cases with moderate symptoms generally warrant aggressive treatment given good prognosis and reasonable cost-benefit ratios. Advanced cases with severe respiratory compromise, prolonged illness, or failure to respond to initial therapy present more difficult decisions. The economic value of the individual animal relative to treatment costs influences decisions, particularly for commercial operations. Chronic cases with permanent lung damage may be culled rather than maintained as poor performers. Food safety requirements mandate proper withdrawal time observance, which may influence treatment choices or marketing timelines. Veterinary consultation ensures appropriate treatment selection and helps navigate complex decision-making in challenging cases.

Recovery timelines for Pasteurella pneumonia vary considerably based on disease severity at treatment initiation, appropriateness of therapy, and individual animal factors. Mild cases treated promptly may show dramatic improvement within 24-48 hours, with fever resolution and improved attitude being early indicators of response. However, complete recovery of damaged lung tissue requires weeks to months, during which animals remain more susceptible to relapse or reinfection. Moderate cases typically require 7-14 days before clinical signs fully resolve, though subclinical healing continues much longer. Severe cases that survive may require months of recovery and may never regain full respiratory function due to permanent scarring and adhesion formation.

Post-treatment care focuses on monitoring for relapse, supporting continued healing, and preventing reinfection during the vulnerable recovery period. Treated animals should be observed daily for return of fever, respiratory distress, or depression that might indicate treatment failure or secondary infection. Continued provision of high-quality nutrition supports immune function and tissue repair. Avoiding stress during the recovery period helps prevent relapse, which means delaying processing procedures, transportation, or other stressful events when possible. Housing recovering animals in clean, well-ventilated areas away from dust and ammonia reduces respiratory irritation. Gradual return to normal activity prevents overexertion of compromised respiratory systems.

Prognosis depends heavily on the extent of lung damage present at treatment initiation and the animal's overall health status. Animals treated within 24-48 hours of symptom onset generally have good to excellent prognosis with appropriate antimicrobial therapy. Delayed treatment or inadequate initial drug selection worsens prognosis significantly, with each day of delay reducing the likelihood of complete recovery. Animals with severe consolidation affecting more than one-third of lung tissue carry guarded prognosis even with aggressive treatment. Pre-existing health problems, extreme young or old age, and concurrent infections all negatively impact prognosis. Chronic cases that survive acute illness often remain compromised performers unlikely to achieve genetic potential.

Return to production considerations must account for both animal recovery status and any drug withdrawal requirements following treatment. Withdrawal times for meat and milk vary by drug and must be strictly observed to ensure food safety. Animals intended for near-term slaughter may have treatment options limited by withdrawal time requirements. Performance expectations should be adjusted for animals recovering from significant pneumonia, as lung damage may limit growth rate, feed efficiency, and exercise tolerance. Breeding decisions should consider that severely affected animals may have reduced productivity throughout life. Veterinary guidance helps establish realistic timelines for return to normal production activities based on individual animal response and intended use.

Vaccination protocols form a cornerstone of Pasteurella pneumonia prevention, though vaccines must be combined with management practices for optimal protection. Multiple vaccines targeting Mannheimia haemolytica and Pasteurella multocida are available, including bacterins, toxoids, and modified-live products. Vaccination timing is critical, with immunity requiring 2-4 weeks to develop following vaccination, meaning animals must be vaccinated well before anticipated high-risk periods. Initial vaccination series typically require two doses 2-4 weeks apart, followed by annual boosters. Pre-weaning vaccination of calves and lambs provides protection during the high-risk post-weaning period. Vaccination of cattle before transportation helps prevent shipping fever. Veterinary guidance ensures appropriate vaccine selection, timing, and administration protocols for specific operation types and risk levels.

Biosecurity measures prevent introduction of highly virulent bacterial strains and reduce transmission pressure within herds. Quarantine of newly purchased animals for at least 2-3 weeks allows observation for respiratory disease before exposure to established animals. Sourcing animals from single origins rather than commingled auction purchases reduces pathogen diversity and stress. Avoiding mixing animals of different ages and sources limits transmission from carriers to susceptible individuals. Visitor control and sanitation of equipment moving between farms prevents mechanical transmission. While Pasteurella organisms are ubiquitous in livestock populations, limiting introduction of novel strains and reducing overall pathogen load helps maintain herd health.

Nutritional prevention supports robust immune function capable of preventing commensal bacteria from becoming pathogenic invaders. Adequate vitamin A levels are essential for maintaining respiratory epithelium integrity, the first line of defense against respiratory infection. Trace minerals including selenium, copper, and zinc play critical roles in immune cell function. Proper protein and energy intake supports overall health and immune competence. Ensuring adequate colostrum intake in neonates provides passive antibodies and immune factors protecting young animals during the vulnerable early weeks. Avoiding nutritional stress through consistent feeding programs and gradual diet changes reduces immune suppression associated with metabolic disruption.

Management practices addressing known risk factors provide practical disease prevention through everyday operational decisions. Reducing stress is paramount, which means gentle handling, avoiding unnecessary procedures, and timing necessary interventions to avoid cumulative stress effects. Providing adequate ventilation in housing removes airborne pathogens and reduces respiratory irritation from ammonia and dust. Maintaining appropriate stocking densities prevents overcrowding stress and reduces pathogen transmission efficiency. Minimizing transportation distance and duration when movement is necessary reduces shipping stress. Allowing adequate recovery time between stressful events prevents immune suppression from cumulative stress effects.

Quarantine and testing protocols apply primarily to controlling highly pathogenic strains or managing outbreak situations. Isolating clinically affected animals prevents ongoing transmission to healthy herdmates and allows focused nursing care. Quarantine of animals returning from shows, sales, or other outside events before reintegration with the main herd prevents introduction of novel pathogens. Testing plays limited role in routine Pasteurella management since healthy carriers are common, but may be valuable during outbreak investigations to characterize strains and susceptibility patterns. Postmortem examination of fatal cases provides valuable diagnostic and epidemiological information. Working with veterinary professionals to develop operation-specific prevention programs ensures the most effective use of available tools and resources.

Daily management and monitoring for Pasteurella pneumonia prevention requires consistent observation of animal health status and early detection of problems. Producers should observe all animals daily, watching for early signs of respiratory disease including separation from the group, decreased feed intake, mild depression, and subtle breathing changes. Particular attention to recently stressed animals such as newly weaned, newly purchased, or recently transported stock helps catch disease in its earliest, most treatable stages. Establishing normal patterns allows recognition of deviations that might indicate developing problems. Training all farm personnel in recognition of early respiratory disease signs ensures coverage during all hours and operations.

Housing and environmental management significantly impact respiratory disease risk by controlling exposure to irritants and pathogens. Adequate ventilation is essential, providing at least four air exchanges per hour in enclosed facilities to remove airborne pathogens, ammonia, and moisture. Avoiding drafts while maintaining air movement requires careful facility design and management. Controlling dust through proper bedding selection, avoiding feeding finely ground feeds, and managing dry lot surfaces reduces respiratory irritation. Maintaining clean, dry bedding reduces ammonia generation and removes contaminated material from the animal environment. Stocking density management prevents overcrowding with its associated stress and enhanced disease transmission.

Herd health programs should incorporate respiratory disease prevention as a core component alongside other health management priorities. Vaccination programs targeting common respiratory pathogens should be timed to provide protection before high-risk periods. Parasite control programs reduce immune suppression and concurrent disease that predisposes to bacterial pneumonia. Processing procedures including castration, dehorning, and vaccination should be planned to minimize cumulative stress effects. Nutritional programs should ensure adequate vitamin and mineral status for optimal immune function. Working with a veterinarian to develop comprehensive herd health programs ensures integration of all health management components.

Record keeping and monitoring systems support effective respiratory disease prevention and outbreak response. Individual animal identification enables tracking of health events and treatment responses. Recording all respiratory disease cases including date of onset, symptoms, treatment provided, and outcome helps identify patterns and evaluate intervention effectiveness. Monitoring mortality rates and causes of death identifies emerging problems requiring attention. Tracking arrival and movement dates for purchased animals allows correlation with disease events. Production records including growth rates, feed efficiency, and reproduction help quantify the impact of respiratory disease on operation performance.

Economic considerations influence prevention investment decisions and must be balanced against disease risk and impact. Vaccination costs are modest relative to the potential cost of disease outbreaks but represent real expenses requiring justification. Facility modifications improving ventilation may require significant capital investment but provide long-term benefits for disease control and animal performance. Management changes affecting animal flow, grouping, and stress reduction may have minimal direct costs but require planning and coordination to implement. The economic impact of subclinical disease on performance is often underestimated, making prevention investments appear more favorable when full costs are considered. Working with veterinary and economic advisors helps producers make informed decisions about prevention investments appropriate for their specific operations and risk levels.

All breeds of cattle, sheep, goats, and other livestock are susceptible to Pasteurella pneumonia, with no breed demonstrating complete resistance to infection. However, breed differences in disease susceptibility and response have been observed that may relate to genetic variations in immune function, stress response, or respiratory anatomy. Bos indicus cattle breeds including Brahman and their crosses show somewhat greater resistance to respiratory disease compared to British and Continental Bos taurus breeds, possibly due to adaptation to environmental stressors. Fine-wool sheep breeds may show increased respiratory disease susceptibility compared to coarse-wool or hair sheep breeds. These breed tendencies influence but do not eliminate risk, requiring attention to prevention and management regardless of breed.

Production type considerations affect Pasteurella pneumonia risk more significantly than breed in many practical situations. Feedlot cattle face extremely high respiratory disease risk due to the combination of transportation stress, commingling, and intensive management inherent in this production system. Dairy calves raised in hutches may have lower respiratory disease incidence than those in group housing, though this varies with facility design and management. Show animals experiencing repeated transportation and pathogen exposure at events face ongoing respiratory disease risk. Commercial meat animals destined for near-term slaughter may receive less aggressive treatment than breeding stock, affecting disease outcomes. Understanding how production system characteristics influence risk helps target prevention efforts appropriately.

Genetic selection for respiratory disease resistance remains limited by the complex, multifactorial nature of disease susceptibility. No single gene or simple genetic marker reliably predicts Pasteurella pneumonia resistance, preventing straightforward genetic selection. Expected progeny differences (EPDs) for some cattle breeds now include respiratory disease traits, allowing selection against susceptibility within those populations. Selection for overall robustness and reduced health problems indirectly improves disease resistance over generations. Culling animals with repeated respiratory disease episodes removes susceptible genetics from breeding populations. Avoiding inbreeding helps maintain genetic diversity supporting immune function. Working with breed associations and genetic consultants can help producers understand options for genetic improvement in disease resistance, though management factors remain more immediately influential than genetics for most operations.

Several conditions commonly co-occur with or predispose to Pasteurella pneumonia through their effects on respiratory defenses and immune function. Viral respiratory infections including infectious bovine rhinotracheitis, bovine viral diarrhea, parainfluenza-3, and bovine respiratory syncytial virus frequently precede bacterial pneumonia by damaging respiratory epithelium and suppressing local immunity. Mycoplasma infections cause their own respiratory disease and predispose to secondary Pasteurella infection. Internal parasitism, particularly lungworm infection, creates respiratory compromise and immune suppression favoring bacterial colonization. Nutritional deficiencies of vitamins and trace minerals impair immune function. These predisposing conditions should be addressed as part of comprehensive respiratory disease prevention programs.

Differential diagnosis for respiratory disease in livestock includes numerous conditions producing similar clinical signs that must be distinguished from Pasteurella pneumonia. Mycoplasma pneumonia causes respiratory disease that may be clinically indistinguishable from Pasteurella infection, though mixed infections are common. Aspiration pneumonia following drenching accidents presents with fever and respiratory distress but has a characteristic history. Lungworm infection causes coughing and respiratory difficulty, particularly in young cattle and sheep. Hardware disease in cattle can cause respiratory changes due to diaphragmatic irritation. Viral respiratory infections without secondary bacterial involvement may produce similar early signs. Thorough clinical examination and appropriate diagnostic testing differentiate these conditions.

Complications of Pasteurella pneumonia reflect the severe tissue damage possible with this condition and shape long-term outcomes for affected animals. Chronic pneumonia with permanent lung scarring develops in animals with extensive disease, particularly when treatment is delayed or inadequate. Pleural adhesions form following pleuritis, restricting lung expansion and reducing respiratory capacity. Pulmonary abscesses may develop, creating chronic infection foci and ongoing illness. Septicemia with spread of infection to other organs can occur in severe cases. Chronic poor performance with reduced growth, poor feed efficiency, and exercise intolerance reflects permanent respiratory compromise in recovered animals. These complications emphasize the importance of early, aggressive treatment and comprehensive prevention programs to limit disease occurrence and severity.